The mean cyt c release to BAD minus HRK peptide, a metric for BCL-2 dependence [18], was 72.8% for CLL versus 18.8% for RS (Fig. 2A, P < 0.0001). Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.